PP-019 Comparing neonatal outcomes of pregnant women treated for opioid use disorder (OUD) with mono-buprenorphine to neonatal outcomes of pregnant women treated for oud with combination Buprenorphine + Naloxone

Ashlyn Hodges,

Martin Olsen,

Lori Moore,

Nicole Lewis,

Article info

PP-019 Comparing neonatal outcomes of pregnant women treated for opioid use disorder (OUD) with mono-buprenorphine to neonatal outcomes of pregnant women treated for OUD with combination Buprenorphine + Naloxone. Perinatal Journal 2024;32(2024):15-17 DOI: 10.59215/prn.24.032supp019

Author(s) Information

Ashlyn Hodges¹ (Data Collector, Data Analyst, Results Interpreter, Literature Researcher, Manuscript Writer)

Martin Olsen¹ (Project Initiator, Study Supervisor)

Lori Moore¹ (Study Designer, Study Supervisor, Data Collector, Results Interpreter, Final Reviewer)

Nicole Lewis² (Data Analyst)

1. East Tennessee State University, Quillen College of Medicine, Department of Obstetrics and Gynecology, Johnson City, United States

2. East Tennessee State University, Quillen College of Medicine, Department of Obstetrics and Gynecology, Knoxville, United States

Correspondence

Ashlyn Hodges, East Tennessee State University, Quillen College of Medicine, Department of Obstetrics and Gynecology, Johnson City, United States,
ashlynhodges123@gmail.com

Publication History

Manuscript Received: May 02, 2024
Manuscript Accepted: May 08, 2024
Publication date: May 18, 2024

Conflicts of Interest

No conflicts declared.

Article's type

Abstract (Formatted)

Pages

15-17

Article info

Online publication date: May 18, 2024

Perinatal Journal 2024; 32 (2024)

DOI

10.59215/prn.24.032supp019

Download as PDF